NEW YORK (360Dx) – Nikon Instruments and OptraScan today announced a partnership to accelerate the adoption of affordable digital pathology in North America.
Nikon will distribute OptraScan's brightfield and fluorescence whole-slide imaging scanners with capacity from one to 120 slides. Nikon will also distribute OptraScan's integrated telepathology, and artificial intelligence- and machine learning-based analytics solutions.
Financial and other terms of the deal were not disclosed.
"Combining our automated whole slide scanners and AI-enabled analytics together with Nikon’s strong market presence, this alliance will serve compelling propositions to our customers for quickly implementing our most advanced and affordable digital pathology solutions," OptraScan Founder and CEO Abhi Gholap said in a statement.
Optrascan offers subscription-based services to pathologists who don't want to pay the high instrument costs associated with digital pathology technology. Its systems, also called Optrascan, enable the acquisition of whole-slide images, as well as viewing, sharing, on-demand analysis, and management of digital slides.
Last month, the company's whole-slide scanners received CE marking for in vitro diagnostic use in the European Union.
In March, the company launched the third generation version of the Optrascan system.
Nikon Instruments is a division of Nikon and is based in Melville, New York. OptraScan is based in San Jose, California.